CRNX vs NVS
Crinetics Pharmaceuticals Inc (CRNX) versus NVS (NVS) — a side-by-side from cached financials, not a winner call.
Crinetics Pharmaceuticals Inc (CRNX) is a biotechnology company listed on US.
NVS (NVS) common stock.
Latest reported CRNX revenue for 2026-06-30 was $35.9M. Net income was -$248.7M. CRNX currently screens at market cap $2.76B.
NVS does not have a complete income-statement cache yet.
CRNX currently screens at market cap $2.76B. NVS currently screens at market cap $0.
Not investment advice. Open the CRNX and NVS stock pages for the full models.
Not investment advice.